GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clovis Oncology Inc (LTS:0A7C) » Definitions » 12-1 Month Momentum %

Clovis Oncology (LTS:0A7C) 12-1 Month Momentum % : N/A% (As of Jun. 04, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clovis Oncology 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-04), Clovis Oncology's 12-1 Month Momentum % is N/A%.

The industry rank for Clovis Oncology's 12-1 Month Momentum % or its related term are showing as below:

LTS:0A7C's 12-1 Month Momentum % is not ranked *
in the Biotechnology industry.
Industry Median: -24.245
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Clovis Oncology's 12-1 Month Momentum %

For the Biotechnology subindustry, Clovis Oncology's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clovis Oncology's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clovis Oncology's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Clovis Oncology's 12-1 Month Momentum % falls into.



Clovis Oncology  (LTS:0A7C) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clovis Oncology  (LTS:0A7C) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Clovis Oncology 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Clovis Oncology's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clovis Oncology (LTS:0A7C) Business Description

Traded in Other Exchanges
N/A
Address
5500 Flatiron Parkway, Suite 100, Boulder, CO, USA, 80301
Clovis Oncology Inc is a biopharmaceutical company. It is focused on acquiring, developing, and commercializing anti-cancer agents in the United States, the EU, and additional international markets. The firm targets its development programs for the treatment of specific subsets of cancer populations. Its product candidate includes Rucaparib. Rucaparib is an oral small molecule inhibitor of poly ADP-ribose polymerase, is marketed in the United States for two indications specific to the recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. The company has two segments U.S and ex-U.S based on geograhic areas, with majority of its revenue coming from U.S.

Clovis Oncology (LTS:0A7C) Headlines

No Headlines